MADRIGAL PHARMACEUTICALS INC (MDGL) Stock Balance Sheet
NASDAQ:MDGL • US5588681057
Current stock price
507.83 USD
+45.9 (+9.94%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | 2.73M | N/A | N/A | |||
| Cash Equivalents | 198.69M | 100.02M | 97.19M | 331.50M | 36.30M | |||
| Marketable Securities | 784.87M | 826.23M | 534.22M | 27.20M | 234.10M | |||
| Receivables | 134.48M | 53.82M | N/A | N/A | N/A | |||
| Inventories | 74.84M | 34.07M | N/A | N/A | N/A | |||
| Other Current Assets | 52.89M | 18.79M | 3.15M | 2.60M | 1.30M | |||
| Total Current Assets | 1.25B | 1.03B | 637.28M | 361.40M | 271.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 6.44M | 4.59M | 3.27M | 1.20M | 1.60M | |||
| Intangibles | 7.38M | 4.73M | N/A | N/A | N/A | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | 1.65M | |||
| Total Non-Current Assets | 13.82M | 9.32M | 3.27M | 1.20M | 1.60M | |||
| TOTAL ASSETS | 1.26B | 1.04B | 640.55M | 362.60M | 273.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 261.41M | 125.68M | 90.51M | 92.10M | 55.50M | |||
| Accounts Payable | 48.88M | 43.60M | 28.04M | 23.80M | 21.40M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 76.84M | |||
| Total Current Liabilities | 310.29M | 169.28M | 118.55M | 115.90M | 76.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 339.88M | 117.57M | 115.48M | 49.30M | 0.00 | |||
| Other Non-Current Liabilities | 6.73M | 1.02M | 1.19M | 0.00 | 400.00K | |||
| Total Non-Current Liabilities | 346.61M | 118.59M | 116.67M | 49.30M | 400.00K | |||
| TOTAL LIABILITIES | 656.90M | 287.86M | 235.21M | 165.20M | 77.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -2.09B | -1.80B | -1.34B | -962.70M | -667.30M | |||
| Additional Paid In Capital | 2.69B | 2.56B | 1.74B | 1.16B | 863.50M | |||
| Common Shares | 2.00K | 2.00K | 2.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 873.00K | 468.00K | 468.00K | 0.00 | -100.00K | |||
| Shares Outstanding | 22.84M | 22.00M | 19.88M | 18.10M | 17.10M | |||
| Tangible Book Value per Share | 26.06 | 34.07 | 20.39 | 10.91 | 11.47 | |||
| Total Shareholders' Equity | 602.69M | 754.38M | 405.33M | 197.40M | 196.10M | |||
| TOTAL LIABILITIES AND EQUITY | 1.26B | 1.04B | 640.55M | 362.60M | 273.30M | |||
| Statistics | ||||||||
| Debt/Equity | 0.56 | 0.16 | 0.28 | 0.25 | N/A | |||
| Current Ratio | 4.01 | 6.10 | 5.38 | 3.12 | 3.54 | |||
| Return On Assets (ROA) | -22.89% | -44.70% | -58.33% | -81.47% | -88.47% | |||
| Return On Equity (ROE) | -47.83% | -61.76% | -92.18% | -149.65% | -123.30% | |||
All data in USD , ROIC based on taxRate of 0.21